Kimberley A. Savage

Iron Restriction to Clinical Isolates of Candida albicans by the Novel Chelator DIBI Inhibits Growth and Increases Sensitivity to Azoles<i>In Vitro</i>and<i>In Vivo</i>in a Murine Model of Experimental Vaginitis

Kimberley A. Savage, Maria del Carmen Parquet, Ross Davidson et al. · Antimicrobial Agents and Chemotherapy · 2018 · 54 citations · Full text

Life Sciences, Microbiology, Pharmacology +17

Novel Iron-Chelator DIBI Inhibits Staphylococcus aureus Growth, Suppresses Experimental MRSA Infection in Mice and Enhances the Activities of Diverse Antibiotics in vitro

Maria del Carmen Parquet, Kimberley A. Savage, Ross Davidson et al. · Frontiers in Microbiology · 2018 · 49 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Can the use of a rapid polymerase chain screening method decrease the incidence of nosocomial meticillin-resistant Staphylococcus aureus?

Mamoon A. Aldeyab, Mary P. Kearney, Carmel Hughes et al. · Journal of Hospital Infection · 2008 · 37 citations

Life Sciences, Infectious Diseases, Microbiology +16

Antibiotic-Resistant <i>Acinetobacter baumannii</i> Is Susceptible to the Novel Iron-Sequestering Anti-infective DIBI <i>In Vitro</i> and in Experimental Pneumonia in Mice

Maria del Carmen Parquet, Kimberley A. Savage, David Allan et al. · Antimicrobial Agents and Chemotherapy · 2019 · 30 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14

Iron Sequestrant DIBI, a Potential Alternative for Nares Decolonization of Methicillin-Resistant Staphylococcus aureus, Is Anti-infective and Inhibitory for Mupirocin-Resistant Isolates

Maria del Carmen Parquet, Kimberley A. Savage, Bruce E. Holbein · Antimicrobial Agents and Chemotherapy · 2020 · 14 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17